课题基金 / 基金详情

MOLECULAR REMEDY OF MITOCHONDRIAL DEFECTS

MOLECULAR REMEDY OF MITOCHONDRIAL DEFECTS
线粒体缺陷的分子修复
批准号:
6752052
负责人:
TAKAO YAGI
金额:
$25.56万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-06-01 至 2005-05-31

项目摘要

项目成果

TAKAO YAGI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It has been reported that many human diseases are associated with defects in the mitochondrial protontranslocating NADH-ubiquinone (UQ) oxidoreductase, also known as complex I. Defects in complex I, which render it dysfunctional, result in the following three problems: (1) impaired ability of the respiratory chain to oxidize NADH back to NAD; (2) impaired ability of this enzyme to pump protons; (3) production of reactive oxygen species (ROS). The overall goal of this grant application is to identify potential areas of treatment and/or remedies for the diseases that result from dysfunctional complex I. Of the three problems described above, impairment of proton pumping at any one of the three proton translocation sites does not appear to present a severe health hazard when compared to the inability of mitochondria to oxidize NADH and/or damage caused by ROS. Yeast (Saccharomyces cerevisiae) mitochondria lack complex I but contain instead a NADH-UQ oxidoreductase composed of a single- subunit (Ndi1). In an initial attempt to tackle the problems associated with dysfunctional complex I, we have attempted to employ the yeast Ndil to transmit electrons from NADH to UQ in mammalian mitochondria lacking a functional complex I. We have demonstrated that the Ndil can be functionally expressed in complex I-deficient Chinese hamster mutant cells (CCL16-B2), complex I deficient human cells (C4T), and human embryonal kidney 293 cells (HEK 293). In all cases the expressed Ndil was correctly localized in the mitochondria. These results indicate that the ND11 gene provides a potentially useful tool for gene therapy of mitochondrial diseases caused by complex I deficiency. The studies planned during this grant period are as follows. (1) Functional expression of the ND11 gene in growth-arrested mammalian cells. (2) Suppression of the ROS in mammalian mitochondria by ND11 transfection. (3) Construction of transgenic mice containing the ND11 gene. (4) Repair of a point mutation in the NDUFA1 gene encoding the MWFE subunit of complex I.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Remedy of Mitochondrial Defects
  • 批准号:
    8792528
  • 项目类别:
  • 资助金额:
    $46.15万
  • 财政年份:
    2011
  • 负责人:
    TAKAO YAGI
  • 依托单位:
Molecular Remedy of Mitochondrial Defects
  • 批准号:
    8607954
  • 项目类别:
  • 资助金额:
    $46.15万
  • 财政年份:
    2011
  • 负责人:
    TAKAO YAGI
  • 依托单位:
Molecular Remedy of Mitochondrial Defects
  • 批准号:
    8051502
  • 项目类别:
  • 资助金额:
    $49.17万
  • 财政年份:
    2011
  • 负责人:
    TAKAO YAGI
  • 依托单位:
Molecular Remedy of Mitochondrial Defects
  • 批准号:
    8212077
  • 项目类别:
  • 资助金额:
    $47.26万
  • 财政年份:
    2011
  • 负责人:
    TAKAO YAGI
  • 依托单位:
海外基金